Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 533

Results For "C"

9540 News Found

Alembic receives EIR for oncology injectable formulation facility at Panelav
Drug Approval | December 12, 2022

Alembic receives EIR for oncology injectable formulation facility at Panelav

This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA


Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
Drug Approval | December 12, 2022

Zydus receives USFDA approval to market Silodosin and Pregabalin capsules

Silodosin capsules treat signs and symptoms of an enlarged prostate gland


PM addresses valedictory function of 9th World Ayurveda Congress
Policy | December 12, 2022

PM addresses valedictory function of 9th World Ayurveda Congress

Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine


PM dedicates AIIMS Nagpur to the nation
Policy | December 12, 2022

PM dedicates AIIMS Nagpur to the nation

The hospital is being developed at a cost of more than Rs. 1,575 crore


National Health Ministers’ Conclave concludes in Varanasi
Policy | December 12, 2022

National Health Ministers’ Conclave concludes in Varanasi

They also released the Operational Guidelines for Wellness activities at AB-HWCs


Entod Pharmaceuticals to launch GLO division
News | December 12, 2022

Entod Pharmaceuticals to launch GLO division

This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma


Merck begins Tender Offer to acquire Imago BioSciences
News | December 12, 2022

Merck begins Tender Offer to acquire Imago BioSciences

As a result, Imago will become a subsidiary of Merck.


GSK announces new global headquarters in central London
News | December 12, 2022

GSK announces new global headquarters in central London

Company to open new headquarters in 2024


Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Clinical Trials | December 12, 2022

Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022

Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes


GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
Clinical Trials | December 12, 2022

GSK’s new data underscore important responses with momelotinib for myelofibrosis patients

48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response